HLNE - Hamilton Lane Incorporated
SEI Investments (NASDAQ: SEIC - Get Free Report) and Hamilton Lane (NASDAQ: HLNE - Get Free Report) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations. Institutional and Insider Ownership 70.6% of SEI Investments
I define dividend growth stocks as those with dividend increases of 5 or more consecutive years. In this monthly series, I rank a selection of dividend growth stocks and present the top 10 stocks for consideration. This month, I'm presenting the top 10 dividend growth stocks with a 5-year yield-on-cost of 2.5% or higher and a consensus upside of at least 5%.
CONSHOHOCKEN, Pa., July 7, 2026 /PRNewswire/ -- Hamilton Lane Incorporated (Nasdaq: HLNE) is scheduled to release financial results for the first fiscal quarter ended June 30, 2026 before the market opens on Tuesday, August 4, 2026.
CONSHOHOCKEN, Pa., July 1, 2026 /PRNewswire/ -- Leading global private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced it has closed on $3.8 billion in total commitments for its Direct Equity strategy in and alongside the Hamilton Lane Equity Opportunities Fund VI ("EO VI" or "the Fund"), reflecting strong investor interest for Hamilton Lane's track record of investment performance and differentiated investment approach.
ATLANTA--(BUSINESS WIRE)--Gridline, the turnkey platform wealth management firms rely on to manage the private markets lifecycle, today announced a strategic partnership and technology integration with Hamilton Lane (Nasdaq: HLNE), a leading global private markets investment firm. Drawing on Hamilton Lane's extensive proprietary private markets data, Gridline has enhanced its AI-powered diligence solution, AltComply, with a new benchmarking engine. Hamilton Lane's dataset offers one of the most.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Hamilton Lane (HLNE) have what it takes?
Hamilton Lane trades at a deep discount, with shares at 60% of estimated fair value despite robust business performance. HLNE's non-GAAP EPS grew 23.1% year-over-year, and management hiked the dividend by 11%, signaling confidence in ongoing cash flow strength. The stock's forward P/E of 12.8 is well below its 9-year average, with a fair value estimate of $141 per share, implying an 81% potential total return by June 2027.
Hamilton Lane says critics misunderstand how private-equity fund stakes are valued, defending the industry's practice of booking gains on discounted secondary-market purchases.
Hamilton Lane Inc (NASDAQ:HLNE) reported mixed results for the fourth quarter on Thursday.
On May 21, 2026, Hamilton Lane Inc (HLNE) shares rose 4.1% to a current price of $88.49. The stock has experienced significant volatility over the past year, tr
Hamilton Lane Incorporated (HLNE) Q4 2026 Earnings Call Transcript
Hamilton Lane NASDAQ: HLNE reported higher fiscal 2026 revenue and earnings growth, while management used the company's fiscal fourth-quarter earnings call to push back against concerns about private markets and highlight momentum in its evergreen fund platform.
While the top- and bottom-line numbers for Hamilton Lane (HLNE) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Hamilton Lane (HLNE) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.21 per share a year ago.
CONSHOHOCKEN, Pa., May 21, 2026 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) today reported its results for the fourth quarter and full fiscal year ended March 31, 2026.
On May 19, 2026, Hamilton Lane Inc (HLNE) shares fell 3.0%, closing at $84.11. The stock has been under pressure, trading within a 52-week range of $84.05 to $1
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- #cosettepharma--Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the company's executive leadership team as it continues to advance its ambitions in specialty pharmaceuticals and expand its commercial platform and portfolio. In this new role, David will oversee all branded commercial functions – including sales, marketing, market access, commerc.
Get a deeper insight into the potential performance of Hamilton Lane (HLNE) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Investors need to pay close attention to HLNE stock based on the movements in the options market lately.
Hamilton Lane (HLNE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.